Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT05816499 · UNKNOWN
Trial details
- NCT number
- NCT05816499
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-16
- Primary completion
- 2024-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.